Chrysemys picta bellii isolate RCT428 chromosome 20, Chrysemys_picta_BioNano-3.0.4, whole genome shotgun sequence.
Chrysemys picta bellii (western painted turtle)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Testudinoidea; Emydidae; Chrysemys.
Physical Mapping and Refinement of the Painted Turtle Genome (Chrysemys picta) Inform Amniote Genome Evolution and Challenge Turtle-Bird Chromosomal Conservation
REFSEQ INFORMATION: The reference sequence is identical to\nCM024788.1.\nAssembly name: Chrysemys_picta_BioNano-3.0.4\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Painted turtle genome\nsequencing consortium on 2020/08/21. The original whole-genome\nshotgun project has the accession AHGY00000000.3.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Painted turtle genome sequencing\n consortium\nAssembly Method :: Newbler v. 2.6\nAssembly Name :: Chrysemys_picta_BioNano-3.0.4\nGenome Coverage :: 19.2x\nSequencing Technology :: 454 Life Sciences\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chrysemys picta Annotation Release\n 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
small lake 1.3 miles south of Potholes Reservoir
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
CMP-N-acetylneuraminate-beta-galactosamide- alpha-2,3-sialyltransferase 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
BMP/retinoic acid inducible neural specific 1
COORDINATES: polyA evidence [ECO:0006239]
BMP/retinoic acid-inducible neural-specific protein 1
CDK5 regulatory subunit associated protein 2, transcript variant X7
CDK5 regulatory subunit associated protein 2, transcript variant X4
CDK5 regulatory subunit associated protein 2, transcript variant X5
CDK5 regulatory subunit associated protein 2, transcript variant X6
CDK5 regulatory subunit associated protein 2, transcript variant X3
CDK5 regulatory subunit associated protein 2, transcript variant X1
CDK5 regulatory subunit associated protein 2, transcript variant X2
CDK5 regulatory subunit-associated protein 2 isoform X4
CDK5 regulatory subunit-associated protein 2 isoform X2
CDK5 regulatory subunit-associated protein 2 isoform X5
CDK5 regulatory subunit-associated protein 2 isoform X6
CDK5 regulatory subunit-associated protein 2 isoform X3
CDK5 regulatory subunit-associated protein 2 isoform X7
CDK5 regulatory subunit-associated protein 2 isoform X1
CDK5 regulatory subunit associated protein 2, transcript variant X8
CDK5 regulatory subunit-associated protein 2 isoform X8
multiple EGF like domains 9, transcript variant X2
multiple EGF like domains 9, transcript variant X1
multiple epidermal growth factor-like domains protein 9 isoform X2
multiple epidermal growth factor-like domains protein 9 isoform X1
collagen alpha-1(XXVII) chain B, transcript variant X2
collagen alpha-1(XXVII) chain B isoform X2
collagen alpha-1(XXVII) chain B, transcript variant X1
collagen alpha-1(XXVII) chain B, transcript variant X4
collagen alpha-1(XXVII) chain B, transcript variant X3
collagen alpha-1(XXVII) chain B, transcript variant X5
collagen alpha-1(XXVII) chain B isoform X1
collagen alpha-1(XXVII) chain B isoform X4
collagen alpha-1(XXVII) chain B isoform X3
collagen alpha-1(XXVII) chain B isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 29% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: alpha-1-acid glycoprotein 1-like
solute carrier family 25 member 25, transcript variant X1
solute carrier family 25 member 25, transcript variant X2
solute carrier family 25 member 25, transcript variant X3
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X1
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X2
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X3
nuclear apoptosis inducing factor 1, transcript variant X1
nuclear apoptosis inducing factor 1, transcript variant X2
family with sequence similarity 102 member A, transcript variant X1
family with sequence similarity 102 member A, transcript variant X2
dolichyl-phosphate mannosyltransferase subunit 2, regulatory, transcript variant X1
dolichol phosphate-mannose biosynthesis regulatory protein isoform X1
dolichyl-phosphate mannosyltransferase subunit 2, regulatory, transcript variant X2
dolichol phosphate-mannose biosynthesis regulatory protein isoform X2
phosphatidylinositol-4-phosphate 5-kinase like 1, transcript variant X1
phosphatidylinositol 4-phosphate 5-kinase-like protein 1 isoform X1
phosphatidylinositol-4-phosphate 5-kinase like 1, transcript variant X3
phosphatidylinositol 4-phosphate 5-kinase-like protein 1 isoform X3
phosphatidylinositol-4-phosphate 5-kinase like 1, transcript variant X2
phosphatidylinositol 4-phosphate 5-kinase-like protein 1 isoform X2
phosphatidylinositol-4-phosphate 5-kinase like 1, transcript variant X4
phosphatidylinositol 4-phosphate 5-kinase-like protein 1 isoform X4
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4, transcript variant X2
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4, transcript variant X1
alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase isoform X2
alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1, 3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase isoform X1
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, transcript variant X5
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, transcript variant X4
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, transcript variant X9
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, transcript variant X3
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, transcript variant X6
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, transcript variant X8
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, transcript variant X7
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 isoform X3
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, transcript variant X2
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 isoform X2
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6, transcript variant X1
alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 isoform X1
adenylate kinase 1, transcript variant X1
adenylate kinase 1, transcript variant X4
adenylate kinase 1, transcript variant X2
adenylate kinase 1, transcript variant X6
adenylate kinase 1, transcript variant X5
adenylate kinase 1, transcript variant X3
folylpolyglutamate synthase, transcript variant X2
folylpolyglutamate synthase, transcript variant X3
folylpolyglutamate synthase, transcript variant X1
folylpolyglutamate synthase, mitochondrial isoform X2
folylpolyglutamate synthase, mitochondrial isoform X3
folylpolyglutamate synthase, mitochondrial isoform X1
folylpolyglutamate synthase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
folylpolyglutamate synthase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
folylpolyglutamate synthase, mitochondrial isoform X5
folylpolyglutamate synthase, mitochondrial isoform X4
cyclin dependent kinase 9, transcript variant X1
cyclin dependent kinase 9, transcript variant X2
SH2 domain containing 3C, transcript variant X1
SH2 domain containing 3C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
SH2 domain-containing protein 3C isoform X1
SH2 domain-containing protein 3C isoform X2
SH2 domain containing 3C, transcript variant X3
SH2 domain-containing protein 3C isoform X3
SH2 domain containing 3C, transcript variant X5
SH2 domain-containing protein 3C isoform X5
SH2 domain containing 3C, transcript variant X4
SH2 domain-containing protein 3C isoform X4
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
tetratricopeptide repeat domain 16, transcript variant X2
tetratricopeptide repeat domain 16, transcript variant X1
tetratricopeptide repeat protein 16 isoform X2
tetratricopeptide repeat protein 16 isoform X1
peptidyl-tRNA hydrolase 1 homolog, transcript variant X3
peptidyl-tRNA hydrolase 1 homolog, transcript variant X1
peptidyl-tRNA hydrolase 1 homolog, transcript variant X2
probable peptidyl-tRNA hydrolase isoform X1
probable peptidyl-tRNA hydrolase isoform X2
probable peptidyl-tRNA hydrolase isoform X3
cilia and flagella associated protein 157, transcript variant X1
cilia and flagella associated protein 157, transcript variant X3
cilia- and flagella-associated protein 157 isoform X3
cilia- and flagella-associated protein 157 isoform X1
cilia and flagella associated protein 157, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cilia- and flagella-associated protein 157 isoform X2
cerebral endothelial cell adhesion molecule, transcript variant X2
cerebral endothelial cell adhesion molecule, transcript variant X1
inactive glycosyltransferase 25 family member 3 isoform X1
inactive glycosyltransferase 25 family member 3 isoform X2
solute carrier family 27 member 4, transcript variant X2
solute carrier family 27 member 4, transcript variant X1
long-chain fatty acid transport protein 4
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ubiquinone biosynthesis protein COQ4 homolog, mitochondrial
TruB pseudouridine synthase family member 2, transcript variant X1
TruB pseudouridine synthase family member 2, transcript variant X2
mitochondrial mRNA pseudouridine synthase TRUB2 isoform X1
mitochondrial mRNA pseudouridine synthase TRUB2 isoform X2
SWI5 homologous recombination repair protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
CDKN1A interacting zinc finger protein 1
bublin coiled coil protein, transcript variant X1
bublin coiled coil protein, transcript variant X3
bublin coiled coil protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
bublin coiled coil protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
bublin coiled coil protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
bublin coiled coil protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
prostaglandin E synthase 2, transcript variant X1
prostaglandin E synthase 2, transcript variant X2
outer dense fiber of sperm tails 2, transcript variant X1
outer dense fiber of sperm tails 2, transcript variant X2
outer dense fiber of sperm tails 2, transcript variant X4
outer dense fiber of sperm tails 2, transcript variant X3
spectrin alpha, non-erythrocytic 1, transcript variant X3
spectrin alpha, non-erythrocytic 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
spectrin alpha, non-erythrocytic 1, transcript variant X1
spectrin alpha, non-erythrocytic 1, transcript variant X2
spectrin alpha, non-erythrocytic 1, transcript variant X4
spectrin alpha, non-erythrocytic 1, transcript variant X5
spectrin alpha, non-erythrocytic 1, transcript variant X6
spectrin alpha, non-erythrocytic 1, transcript variant X7
spectrin alpha, non-erythrocytic 1, transcript variant X8
spectrin alpha chain, non-erythrocytic 1 isoform X1
spectrin alpha chain, non-erythrocytic 1 isoform X5
spectrin alpha chain, non-erythrocytic 1 isoform X2
spectrin alpha chain, non-erythrocytic 1 isoform X6
spectrin alpha chain, non-erythrocytic 1 isoform X4
spectrin alpha chain, non-erythrocytic 1 isoform X7
spectrin alpha chain, non-erythrocytic 1 isoform X8
spectrin alpha chain, non-erythrocytic 1 isoform X9
spectrin alpha chain, non-erythrocytic 1 isoform X3
cytoplasmic dynein 2 intermediate chain 2
SET nuclear proto-oncogene, transcript variant X2
SET nuclear proto-oncogene, transcript variant X1
protein kinase N3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein kinase N3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
serine/threonine-protein kinase N3 isoform X1
serine/threonine-protein kinase N3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger DHHC-type palmitoyltransferase 12
zyg-11 related cell cycle regulator, transcript variant X2
zyg-11 related cell cycle regulator, transcript variant X1
TBC1 domain family member 13, transcript variant X1
TBC1 domain family member 13, transcript variant X2
TBC1 domain family member 13, transcript variant X4
TBC1 domain family member 13, transcript variant X3
SPOUT domain containing methyltransferase 1, transcript variant X3
SPOUT domain containing methyltransferase 1, transcript variant X1
SPOUT domain containing methyltransferase 1, transcript variant X2
SPOUT domain containing methyltransferase 1, transcript variant X4
putative methyltransferase C9orf114 homolog isoform X1
putative methyltransferase C9orf114 homolog isoform X2
putative methyltransferase C9orf114 homolog isoform X3
kynurenine aminotransferase 1, transcript variant X4
kynurenine aminotransferase 1, transcript variant X7
kynurenine aminotransferase 1, transcript variant X2
kynurenine aminotransferase 1, transcript variant X1
kynurenine aminotransferase 1, transcript variant X6
kynurenine aminotransferase 1, transcript variant X3
kynurenine aminotransferase 1, transcript variant X5
kynurenine aminotransferase 1, transcript variant X8
kynurenine--oxoglutarate transaminase 1 isoform X1
kynurenine--oxoglutarate transaminase 1 isoform X2
leucine rich repeat containing 8 VRAC subunit A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
leucine rich repeat containing 8 VRAC subunit A, transcript variant X5
leucine rich repeat containing 8 VRAC subunit A, transcript variant X3
leucine rich repeat containing 8 VRAC subunit A, transcript variant X2
leucine rich repeat containing 8 VRAC subunit A, transcript variant X6
leucine rich repeat containing 8 VRAC subunit A, transcript variant X1
leucine rich repeat containing 8 VRAC subunit A, transcript variant X12
leucine rich repeat containing 8 VRAC subunit A, transcript variant X8
leucine rich repeat containing 8 VRAC subunit A, transcript variant X9
leucine rich repeat containing 8 VRAC subunit A, transcript variant X10
leucine rich repeat containing 8 VRAC subunit A, transcript variant X7
leucine rich repeat containing 8 VRAC subunit A, transcript variant X13
leucine rich repeat containing 8 VRAC subunit A, transcript variant X11
volume-regulated anion channel subunit LRRC8A
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X4
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X5
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X3
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X2
phytanoyl-CoA dioxygenase domain containing 1, transcript variant X1
phytanoyl-CoA dioxygenase domain-containing protein 1 isoform X1
phytanoyl-CoA dioxygenase domain-containing protein 1 isoform X4
phytanoyl-CoA dioxygenase domain-containing protein 1 isoform X2
phytanoyl-CoA dioxygenase domain-containing protein 1 isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
SH3 domain containing GRB2 like, endophilin B2, transcript variant X4
SH3 domain containing GRB2 like, endophilin B2, transcript variant X1
SH3 domain containing GRB2 like, endophilin B2, transcript variant X8
SH3 domain containing GRB2 like, endophilin B2, transcript variant X6
SH3 domain containing GRB2 like, endophilin B2, transcript variant X7
SH3 domain containing GRB2 like, endophilin B2, transcript variant X2
SH3 domain containing GRB2 like, endophilin B2, transcript variant X9
SH3 domain containing GRB2 like, endophilin B2, transcript variant X3
SH3 domain containing GRB2 like, endophilin B2, transcript variant X5
SH3 domain containing GRB2 like, endophilin B2, transcript variant X10
carnitine O-acetyltransferase, transcript variant X1
carnitine O-acetyltransferase, transcript variant X2
carnitine O-acetyltransferase, transcript variant X3
carnitine O-acetyltransferase, transcript variant X4
carnitine O-acetyltransferase isoform X3
carnitine O-acetyltransferase isoform X1
carnitine O-acetyltransferase isoform X2
carnitine O-acetyltransferase isoform X4
protein phosphatase 2 phosphatase activator, transcript variant X1
protein phosphatase 2 phosphatase activator, transcript variant X3
serine/threonine-protein phosphatase 2A activator isoform X1
serine/threonine-protein phosphatase 2A activator isoform X3
protein phosphatase 2 phosphatase activator, transcript variant X2
serine/threonine-protein phosphatase 2A activator isoform X2
immediate early response gene 5-like protein
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X2
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X1
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X4
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X3
N-terminal Xaa-Pro-Lys N-methyltransferase 1 isoform X1
N-terminal Xaa-Pro-Lys N-methyltransferase 1 isoform X2
N-terminal Xaa-Pro-Lys N-methyltransferase 1 isoform X3
ankyrin repeat and SOCS box containing 6, transcript variant X2
ankyrin repeat and SOCS box containing 6, transcript variant X4
ankyrin repeat and SOCS box containing 6, transcript variant X5
ankyrin repeat and SOCS box containing 6, transcript variant X1
ankyrin repeat and SOCS box containing 6, transcript variant X3
ankyrin repeat and SOCS box protein 6 isoform X2
ankyrin repeat and SOCS box protein 6 isoform X1
prostaglandin E synthase, transcript variant X1
prostaglandin E synthase, transcript variant X2
prostaglandin E synthase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
telomere length and silencing protein 1 homolog
ubiquitin specific peptidase 20, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
ubiquitin specific peptidase 20, transcript variant X6
ubiquitin specific peptidase 20, transcript variant X2
ubiquitin specific peptidase 20, transcript variant X1
ubiquitin specific peptidase 20, transcript variant X4
ubiquitin specific peptidase 20, transcript variant X3
ubiquitin specific peptidase 20, transcript variant X5
ubiquitin carboxyl-terminal hydrolase 20 isoform X1
ubiquitin carboxyl-terminal hydrolase 20 isoform X2
ubiquitin carboxyl-terminal hydrolase 20 isoform X3
formin binding protein 1, transcript variant X3
formin binding protein 1, transcript variant X6
formin binding protein 1, transcript variant X4
formin binding protein 1, transcript variant X1
formin binding protein 1, transcript variant X10
formin binding protein 1, transcript variant X8
formin binding protein 1, transcript variant X7
formin binding protein 1, transcript variant X5
formin binding protein 1, transcript variant X2
formin binding protein 1, transcript variant X11
formin binding protein 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
neuronal calcium sensor 1, transcript variant X2
neuronal calcium sensor 1, transcript variant X3
neuronal calcium sensor 1, transcript variant X4
neuronal calcium sensor 1, transcript variant X5
neuronal calcium sensor 1, transcript variant X6
neuronal calcium sensor 1, transcript variant X8
neuronal calcium sensor 1, transcript variant X10
neuronal calcium sensor 1, transcript variant X11
neuronal calcium sensor 1, transcript variant X7
neuronal calcium sensor 1, transcript variant X9
neuronal calcium sensor 1, transcript variant X1
neuronal calcium sensor 1, transcript variant X12
far upstream element binding protein 3, transcript variant X1
far upstream element binding protein 3, transcript variant X7
far upstream element binding protein 3, transcript variant X6
far upstream element binding protein 3, transcript variant X8
far upstream element binding protein 3, transcript variant X2
far upstream element binding protein 3, transcript variant X4
far upstream element binding protein 3, transcript variant X5
far upstream element binding protein 3, transcript variant X9
far upstream element binding protein 3, transcript variant X18
far upstream element binding protein 3, transcript variant X10
far upstream element binding protein 3, transcript variant X13
far upstream element binding protein 3, transcript variant X17
far upstream element binding protein 3, transcript variant X19
far upstream element binding protein 3, transcript variant X14
far upstream element-binding protein 3 isoform X1
far upstream element-binding protein 3 isoform X7
far upstream element-binding protein 3 isoform X6
far upstream element-binding protein 3 isoform X8
far upstream element-binding protein 3 isoform X2
far upstream element-binding protein 3 isoform X4
far upstream element-binding protein 3 isoform X5
far upstream element-binding protein 3 isoform X9
far upstream element-binding protein 3 isoform X18
far upstream element-binding protein 3 isoform X10
far upstream element-binding protein 3 isoform X13
far upstream element-binding protein 3 isoform X17
far upstream element-binding protein 3 isoform X19
far upstream element-binding protein 3 isoform X14
far upstream element binding protein 3, transcript variant X3
far upstream element binding protein 3, transcript variant X11
far upstream element binding protein 3, transcript variant X12
far upstream element binding protein 3, transcript variant X15
far upstream element binding protein 3, transcript variant X16
far upstream element-binding protein 3 isoform X3
far upstream element-binding protein 3 isoform X11
far upstream element-binding protein 3 isoform X12
far upstream element-binding protein 3 isoform X15
far upstream element-binding protein 3 isoform X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
PR domain zinc finger protein 12 isoform X1
PR domain zinc finger protein 12 isoform X2
ABL proto-oncogene 1, non-receptor tyrosine kinase, transcript variant X1
ABL proto-oncogene 1, non-receptor tyrosine kinase, transcript variant X2
ABL proto-oncogene 1, non-receptor tyrosine kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
fibrinogen C domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
allograft inflammatory factor 1 like, transcript variant X2
allograft inflammatory factor 1 like, transcript variant X1
allograft inflammatory factor 1 like, transcript variant X3
allograft inflammatory factor 1-like isoform X1
allograft inflammatory factor 1-like isoform X2
allograft inflammatory factor 1 like, transcript variant X4
allograft inflammatory factor 1-like isoform X3
nuclear pore complex protein Nup214 isoform X1
nuclear pore complex protein Nup214 isoform X4
nuclear pore complex protein Nup214 isoform X2
nuclear pore complex protein Nup214 isoform X3
nuclear pore complex protein Nup214 isoform X5
nuclear pore complex protein Nup214 isoform X6
nuclear pore complex protein Nup214 isoform X7
family with sequence similarity 78 member A, transcript variant X2
family with sequence similarity 78 member A, transcript variant X1
phospholipid phosphatase 7 (inactive), transcript variant X2
phospholipid phosphatase 7 (inactive), transcript variant X3
phospholipid phosphatase 7 (inactive), transcript variant X1
proline rich coiled-coil 2B, transcript variant X4
proline rich coiled-coil 2B, transcript variant X5
proline rich coiled-coil 2B, transcript variant X8
proline rich coiled-coil 2B, transcript variant X1
proline rich coiled-coil 2B, transcript variant X7
proline rich coiled-coil 2B, transcript variant X6
proline rich coiled-coil 2B, transcript variant X2
proline rich coiled-coil 2B, transcript variant X3
proline rich coiled-coil 2B, transcript variant X9
proline rich coiled-coil 2B, transcript variant X10
protein O-mannosyltransferase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
protein O-mannosyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
protein O-mannosyltransferase 1, transcript variant X4
protein O-mannosyltransferase 1, transcript variant X1
protein O-mannosyl-transferase 1 isoform X1
protein O-mannosyl-transferase 1 isoform X2
protein O-mannosyl-transferase 1 isoform X3
protein O-mannosyl-transferase 1 isoform X4
uridine-cytidine kinase 1, transcript variant X3
uridine-cytidine kinase 1, transcript variant X2
uridine-cytidine kinase 1, transcript variant X1
uridine-cytidine kinase 1, transcript variant X4
proline rich transmembrane protein 1B, transcript variant X3
proline rich transmembrane protein 1B, transcript variant X1
proline rich transmembrane protein 1B, transcript variant X2
Rap guanine nucleotide exchange factor 1, transcript variant X3
Rap guanine nucleotide exchange factor 1, transcript variant X6
Rap guanine nucleotide exchange factor 1, transcript variant X2
Rap guanine nucleotide exchange factor 1, transcript variant X8
Rap guanine nucleotide exchange factor 1, transcript variant X5
Rap guanine nucleotide exchange factor 1, transcript variant X1
Rap guanine nucleotide exchange factor 1, transcript variant X4
Rap guanine nucleotide exchange factor 1, transcript variant X12
Rap guanine nucleotide exchange factor 1, transcript variant X11
Rap guanine nucleotide exchange factor 1, transcript variant X10
Rap guanine nucleotide exchange factor 1, transcript variant X9
Rap guanine nucleotide exchange factor 1, transcript variant X7
rap guanine nucleotide exchange factor 1 isoform X12
rap guanine nucleotide exchange factor 1 isoform X11
rap guanine nucleotide exchange factor 1 isoform X6
rap guanine nucleotide exchange factor 1 isoform X10
rap guanine nucleotide exchange factor 1 isoform X2
rap guanine nucleotide exchange factor 1 isoform X9
rap guanine nucleotide exchange factor 1 isoform X8
rap guanine nucleotide exchange factor 1 isoform X5
rap guanine nucleotide exchange factor 1 isoform X1
rap guanine nucleotide exchange factor 1 isoform X3
rap guanine nucleotide exchange factor 1 isoform X4
rap guanine nucleotide exchange factor 1 isoform X7
Rap guanine nucleotide exchange factor 1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
mediator complex subunit 27, transcript variant X2
mediator complex subunit 27, transcript variant X1
mediator of RNA polymerase II transcription subunit 27 isoform X2
mediator of RNA polymerase II transcription subunit 27 isoform X1
mediator complex subunit 27, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
mediator complex subunit 27, transcript variant X3
mediator complex subunit 27, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 27 isoform X3
mediator complex subunit 27, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
mediator complex subunit 27, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 27 isoform X7
mediator complex subunit 27, transcript variant X6
mediator of RNA polymerase II transcription subunit 27 isoform X4
mediator complex subunit 27, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 27 isoform X6
mediator complex subunit 27, transcript variant X8
mediator of RNA polymerase II transcription subunit 27 isoform X5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transcription termination factor 1
cilia and flagella associated protein 77
cilia- and flagella-associated protein 77
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DEAD-box helicase 31, transcript variant X1
probable ATP-dependent RNA helicase DDX31 isoform X1
DEAD-box helicase 31, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX31 isoform X2
general transcription factor IIIC subunit 4, transcript variant X2
general transcription factor IIIC subunit 4, transcript variant X3
general transcription factor IIIC subunit 4, transcript variant X1
general transcription factor 3C polypeptide 4 isoform X1
general transcription factor 3C polypeptide 4 isoform X3
general transcription factor 3C polypeptide 4 isoform X2
sperm acrosome associated 9, transcript variant X1
sperm acrosome associated 9, transcript variant X2
sperm acrosome-associated protein 9 isoform X2
sperm acrosome-associated protein 9 isoform X1
TSC complex subunit 1, transcript variant X1
TSC complex subunit 1, transcript variant X4
TSC complex subunit 1, transcript variant X2
TSC complex subunit 1, transcript variant X5
TSC complex subunit 1, transcript variant X8
TSC complex subunit 1, transcript variant X6
TSC complex subunit 1, transcript variant X7
TSC complex subunit 1, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
growth factor independent 1B transcriptional repressor, transcript variant X1
growth factor independent 1B transcriptional repressor, transcript variant X2
general transcription factor IIIC subunit 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
general transcription factor IIIC subunit 5, transcript variant X1
general transcription factor 3C polypeptide 5 isoform X1
general transcription factor IIIC subunit 5, transcript variant X3
general transcription factor 3C polypeptide 5 isoform X2
ral guanine nucleotide dissociation stimulator, transcript variant X5
ral guanine nucleotide dissociation stimulator, transcript variant X4
ral guanine nucleotide dissociation stimulator, transcript variant X1
ral guanine nucleotide dissociation stimulator, transcript variant X2
ral guanine nucleotide dissociation stimulator, transcript variant X3
ral guanine nucleotide dissociation stimulator, transcript variant X6
ral guanine nucleotide dissociation stimulator isoform X5
ral guanine nucleotide dissociation stimulator isoform X4
ral guanine nucleotide dissociation stimulator isoform X6
ral guanine nucleotide dissociation stimulator isoform X3
ral guanine nucleotide dissociation stimulator isoform X2
ral guanine nucleotide dissociation stimulator isoform X1
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group), transcript variant X1
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group), transcript variant X2
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group), transcript variant X3
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 isoform X1
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 isoform X2
coiled-coil domain-containing protein 180
histo-blood group ABO system transferase 1-like, transcript variant X2
histo-blood group ABO system transferase 1-like, transcript variant X1
histo-blood group ABO system transferase 1-like, transcript variant X3
histo-blood group ABO system transferase 1-like, transcript variant X4
histo-blood group ABO system transferase-like isoform X2
histo-blood group ABO system transferase-like isoform X1
histo-blood group ABO system transferase-like isoform X3
histo-blood group ABO system transferase 1-like isoform X4
histo-blood group ABO system transferase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 275 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
histo-blood group ABO system transferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 279 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
histo-blood group ABO system transferase, transcript variant X3
histo-blood group ABO system transferase, transcript variant X4
histo-blood group ABO system transferase isoform X3
histo-blood group ABO system transferase isoform X2
mediator of RNA polymerase II transcription subunit 22-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 22-like, transcript variant X2
mediator of RNA polymerase II transcription subunit 22-like, transcript variant X3
mediator of RNA polymerase II transcription subunit 22-like, transcript variant X6
mediator of RNA polymerase II transcription subunit 22-like, transcript variant X1
mediator of RNA polymerase II transcription subunit 22-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 22-like, transcript variant X7
mediator of RNA polymerase II transcription subunit 22-like
histo-blood group ABO system transferase, transcript variant X1
histo-blood group ABO system transferase, transcript variant X6
histo-blood group ABO system transferase, transcript variant X5
histo-blood group ABO system transferase isoform X1
histo-blood group ABO system transferase isoform X4
histo-blood group ABO system transferase isoform X5
mediator of RNA polymerase II transcription subunit 22, transcript variant X2
mediator of RNA polymerase II transcription subunit 22, transcript variant X1
mediator of RNA polymerase II transcription subunit 22 isoform X1
mediator of RNA polymerase II transcription subunit 22 isoform X2
ribosomal protein L7a, transcript variant X1
ribosomal protein L7a, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00069
COORDINATES: nucleotide motif:Rfam:12.0:RF00049
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
serine/threonine kinase like domain containing 1, transcript variant X7
serine/threonine kinase like domain containing 1, transcript variant X6
serine/threonine kinase like domain containing 1, transcript variant X1
serine/threonine kinase like domain containing 1, transcript variant X8
serine/threonine kinase like domain containing 1, transcript variant X2
serine/threonine kinase like domain containing 1, transcript variant X4
serine/threonine kinase like domain containing 1, transcript variant X3
serine/threonine kinase-like domain-containing protein STKLD1 isoform X1
serine/threonine kinase-like domain-containing protein STKLD1 isoform X7
serine/threonine kinase-like domain-containing protein STKLD1 isoform X2
serine/threonine kinase-like domain-containing protein STKLD1 isoform X5
serine/threonine kinase-like domain-containing protein STKLD1 isoform X6
serine/threonine kinase-like domain-containing protein STKLD1 isoform X3
serine/threonine kinase like domain containing 1, transcript variant X5
serine/threonine kinase like domain containing 1, transcript variant X9
serine/threonine kinase-like domain-containing protein STKLD1 isoform X4
serine/threonine kinase-like domain-containing protein STKLD1 isoform X8
A disintegrin and metalloproteinase with thrombospondin motifs 7-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
A disintegrin and metalloproteinase with thrombospondin motifs 7-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 7-like isoform X2
uncharacterized protein LOC101944645 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 13, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 13 isoform X3
A disintegrin and metalloproteinase with thrombospondin motifs 13 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 13 isoform X2
calcium channel flower domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
family with sequence similarity 163 member B, transcript variant X2
family with sequence similarity 163 member B, transcript variant X1
sarcosine dehydrogenase, transcript variant X1
sarcosine dehydrogenase, mitochondrial isoform X1
sarcosine dehydrogenase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
sarcosine dehydrogenase, mitochondrial isoform X2
vav guanine nucleotide exchange factor 2, transcript variant X5
vav guanine nucleotide exchange factor 2, transcript variant X3
vav guanine nucleotide exchange factor 2, transcript variant X1
vav guanine nucleotide exchange factor 2, transcript variant X2
guanine nucleotide exchange factor VAV2 isoform X3
guanine nucleotide exchange factor VAV2 isoform X2
guanine nucleotide exchange factor VAV2 isoform X1
guanine nucleotide exchange factor VAV2 isoform X4
vav guanine nucleotide exchange factor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
WD repeat domain 5, transcript variant X1
WD repeat domain 5, transcript variant X2
WD repeat-containing protein 5 isoform X1
WD repeat-containing protein 5 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
retinoid X receptor alpha, transcript variant X3
retinoid X receptor alpha, transcript variant X4
retinoid X receptor alpha, transcript variant X1
retinoid X receptor alpha, transcript variant X2
retinoic acid receptor RXR-alpha isoform X4
retinoic acid receptor RXR-alpha isoform X3
retinoic acid receptor RXR-alpha isoform X1
retinoic acid receptor RXR-alpha isoform X2
collagen type V alpha 1 chain, transcript variant X1
collagen type V alpha 1 chain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 26, transcript variant X3
protein phosphatase 1 regulatory subunit 26, transcript variant X2
protein phosphatase 1 regulatory subunit 26, transcript variant X1
protein phosphatase 1 regulatory subunit 26
COORDINATES: nucleotide motif:Rfam:12.0:RF00560
divergent protein kinase domain 1B, transcript variant X1
divergent protein kinase domain 1B, transcript variant X2
divergent protein kinase domain 1B isoform X1
divergent protein kinase domain 1B isoform X2
1-acylglycerol-3-phosphate O-acyltransferase 2, transcript variant X2
1-acylglycerol-3-phosphate O-acyltransferase 2, transcript variant X1
1-acyl-sn-glycerol-3-phosphate acyltransferase beta isoform X1
1-acyl-sn-glycerol-3-phosphate acyltransferase beta isoform X2
EGF like domain multiple 7, transcript variant X20
EGF like domain multiple 7, transcript variant X3
epidermal growth factor-like protein 7 isoform X3
epidermal growth factor-like protein 7 isoform X7
EGF like domain multiple 7, transcript variant X14
EGF like domain multiple 7, transcript variant X16
EGF like domain multiple 7, transcript variant X15
EGF like domain multiple 7, transcript variant X26
EGF like domain multiple 7, transcript variant X25
EGF like domain multiple 7, transcript variant X24
EGF like domain multiple 7, transcript variant X29
EGF like domain multiple 7, transcript variant X28
EGF like domain multiple 7, transcript variant X21
EGF like domain multiple 7, transcript variant X22
EGF like domain multiple 7, transcript variant X10
EGF like domain multiple 7, transcript variant X7
EGF like domain multiple 7, transcript variant X4
EGF like domain multiple 7, transcript variant X8
EGF like domain multiple 7, transcript variant X5
EGF like domain multiple 7, transcript variant X27
EGF like domain multiple 7, transcript variant X17
EGF like domain multiple 7, transcript variant X9
EGF like domain multiple 7, transcript variant X6
EGF like domain multiple 7, transcript variant X23
EGF like domain multiple 7, transcript variant X13
EGF like domain multiple 7, transcript variant X1
EGF like domain multiple 7, transcript variant X2
EGF like domain multiple 7, transcript variant X12
EGF like domain multiple 7, transcript variant X11
EGF like domain multiple 7, transcript variant X18
EGF like domain multiple 7, transcript variant X19
epidermal growth factor-like protein 7 isoform X9
epidermal growth factor-like protein 7 isoform X5
epidermal growth factor-like protein 7 isoform X2
epidermal growth factor-like protein 7 isoform X1
epidermal growth factor-like protein 7 isoform X6
epidermal growth factor-like protein 7 isoform X4
epidermal growth factor-like protein 7 isoform X8
epidermal growth factor-like protein 7 isoform X10
neurogenic locus notch homolog protein 1 isoform X1
neurogenic locus notch homolog protein 1 isoform X2
neurogenic locus notch homolog protein 1 isoform X3
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X2
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X6
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X1
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X5
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X8
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X10
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X3
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X7
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X4
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X9
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
SEC16 homolog A, endoplasmic reticulum export factor, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
protein transport protein Sec16A isoform X2
protein transport protein Sec16A isoform X6
protein transport protein Sec16A isoform X1
protein transport protein Sec16A isoform X5
protein transport protein Sec16A isoform X8
protein transport protein Sec16A isoform X10
protein transport protein Sec16A isoform X3
protein transport protein Sec16A isoform X7
protein transport protein Sec16A isoform X4
protein transport protein Sec16A isoform X9
inositol polyphosphate-5-phosphatase E, transcript variant X1
inositol polyphosphate-5-phosphatase E, transcript variant X3
inositol polyphosphate-5-phosphatase E, transcript variant X2
phosphatidylinositol polyphosphate 5-phosphatase type IV isoform X1
phosphatidylinositol polyphosphate 5-phosphatase type IV isoform X2
peptidase, mitochondrial processing subunit alpha
mitochondrial-processing peptidase subunit alpha
endosome associated trafficking regulator 1
endosome-associated-trafficking regulator 1
small nuclear RNA activating complex polypeptide 4, transcript variant X2
small nuclear RNA activating complex polypeptide 4, transcript variant X1
snRNA-activating protein complex subunit 4 isoform X1
snRNA-activating protein complex subunit 4 isoform X2
small nuclear RNA activating complex polypeptide 4, transcript variant X3
snRNA-activating protein complex subunit 4 isoform X3
caspase recruitment domain family member 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
caspase recruitment domain family member 9, transcript variant X2
caspase recruitment domain family member 9, transcript variant X3
caspase recruitment domain family member 9, transcript variant X5
caspase recruitment domain family member 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
caspase recruitment domain-containing protein 9 isoform X2
caspase recruitment domain-containing protein 9 isoform X3
caspase recruitment domain-containing protein 9 isoform X1
G protein signaling modulator 1, transcript variant X2
G protein signaling modulator 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
G protein signaling modulator 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
G protein signaling modulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
G protein signaling modulator 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
G protein signaling modulator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
G protein signaling modulator 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
G protein signaling modulator 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
G protein signaling modulator 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
G protein signaling modulator 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
G-protein-signaling modulator 1 isoform X3
G-protein-signaling modulator 1 isoform X5
G-protein-signaling modulator 1 isoform X2
G-protein-signaling modulator 1 isoform X1
G-protein-signaling modulator 1 isoform X4
G-protein-signaling modulator 1 isoform X6
G-protein-signaling modulator 1 isoform X8
G-protein-signaling modulator 1 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 187
quiescin sulfhydryl oxidase 2, transcript variant X1
quiescin sulfhydryl oxidase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
NACC family member 2, transcript variant X1
NACC family member 2, transcript variant X3
NACC family member 2, transcript variant X4
NACC family member 2, transcript variant X2
NACC family member 2, transcript variant X5
UBA domain containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
UBA domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
UBA domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
UBA domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
ubiquitin-associated domain-containing protein 1 isoform X1
ubiquitin-associated domain-containing protein 1 isoform X2
ubiquitin-associated domain-containing protein 1 isoform X3
ubiquitin-associated domain-containing protein 1 isoform X4
calmodulin regulated spectrin associated protein 1
LOW QUALITY PROTEIN: calmodulin-regulated spectrin-associated protein 1
uncharacterized LOC101934528, transcript variant X1
uncharacterized protein LOC101934528 isoform X1
uncharacterized LOC101934528, transcript variant X2
uncharacterized protein LOC101934528 isoform X2
potassium sodium-activated channel subfamily T member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium channel subfamily T member 1 isoform X4
potassium sodium-activated channel subfamily T member 1, transcript variant X2
potassium sodium-activated channel subfamily T member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
potassium sodium-activated channel subfamily T member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
potassium sodium-activated channel subfamily T member 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
potassium sodium-activated channel subfamily T member 1, transcript variant X6
potassium sodium-activated channel subfamily T member 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
potassium channel subfamily T member 1 isoform X2
potassium channel subfamily T member 1 isoform X3
potassium channel subfamily T member 1 isoform X1
potassium channel subfamily T member 1 isoform X5
potassium channel subfamily T member 1 isoform X7
potassium channel subfamily T member 1 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
26S proteasome non-ATPase regulatory subunit 5
PHD finger protein 19, transcript variant X2
PHD finger protein 19, transcript variant X4
PHD finger protein 19, transcript variant X1
PHD finger protein 19, transcript variant X3
TNF receptor associated factor 1, transcript variant X4
TNF receptor associated factor 1, transcript variant X3
TNF receptor associated factor 1, transcript variant X2
TNF receptor associated factor 1, transcript variant X1
TNF receptor-associated factor 1 isoform X3
TNF receptor-associated factor 1 isoform X1
TNF receptor-associated factor 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
RAB14, member RAS oncogene family, transcript variant X2
RAB14, member RAS oncogene family, transcript variant X1
DAB2 interacting protein, transcript variant X7
DAB2 interacting protein, transcript variant X9
DAB2 interacting protein, transcript variant X10
DAB2 interacting protein, transcript variant X3
DAB2 interacting protein, transcript variant X8
DAB2 interacting protein, transcript variant X5
DAB2 interacting protein, transcript variant X6
DAB2 interacting protein, transcript variant X4
DAB2 interacting protein, transcript variant X2
DAB2 interacting protein, transcript variant X1
disabled homolog 2-interacting protein isoform X4
disabled homolog 2-interacting protein isoform X1
disabled homolog 2-interacting protein isoform X5
disabled homolog 2-interacting protein isoform X3
DAB2 interacting protein, transcript variant X11
disabled homolog 2-interacting protein isoform X2
DAB2 interacting protein, transcript variant X14
DAB2 interacting protein, transcript variant X15
DAB2 interacting protein, transcript variant X13
DAB2 interacting protein, transcript variant X17
DAB2 interacting protein, transcript variant X18
DAB2 interacting protein, transcript variant X12
disabled homolog 2-interacting protein isoform X6
DAB2 interacting protein, transcript variant X16
disabled homolog 2-interacting protein isoform X7
disabled homolog 2-interacting protein isoform X8
tubulin tyrosine ligase like 11, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tubulin polyglutamylase TTLL11 isoform X6
tubulin tyrosine ligase like 11, transcript variant X5
tubulin tyrosine ligase like 11, transcript variant X2
tubulin tyrosine ligase like 11, transcript variant X1
tubulin tyrosine ligase like 11, transcript variant X4
tubulin tyrosine ligase like 11, transcript variant X3
tubulin tyrosine ligase like 11, transcript variant X7
tubulin tyrosine ligase like 11, transcript variant X8
tubulin polyglutamylase TTLL11 isoform X5
tubulin polyglutamylase TTLL11 isoform X4
tubulin polyglutamylase TTLL11 isoform X2
tubulin polyglutamylase TTLL11 isoform X3
tubulin polyglutamylase TTLL11 isoform X1
tubulin polyglutamylase TTLL11 isoform X7
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein-like
NADH:ubiquinone oxidoreductase subunit A8
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8
MORN repeat containing 5, transcript variant X5
MORN repeat containing 5, transcript variant X1
MORN repeat containing 5, transcript variant X2
MORN repeat containing 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
MORN repeat containing 5, transcript variant X4
MORN repeat-containing protein 5 isoform X4
MORN repeat-containing protein 5 isoform X1
MORN repeat-containing protein 5 isoform X2
MORN repeat-containing protein 5 isoform X3
MORN repeat-containing protein 5 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
mitochondrial ribosome recycling factor, transcript variant X1
mitochondrial ribosome recycling factor, transcript variant X2
ribosome-recycling factor, mitochondrial isoform X2
ribosome-recycling factor, mitochondrial isoform X1
uncharacterized LOC103306177, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC103306177, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized protein LOC103306177 isoform X1
uncharacterized protein LOC103306177 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00579
zinc finger and BTB domain containing 6, transcript variant X3
zinc finger and BTB domain containing 6, transcript variant X1
zinc finger and BTB domain containing 6, transcript variant X2
zinc finger and BTB domain containing 6, transcript variant X4
zinc finger and BTB domain containing 6, transcript variant X5
zinc finger and BTB domain-containing protein 6
zinc finger and BTB domain containing 26, transcript variant X1
zinc finger and BTB domain containing 26, transcript variant X2
zinc finger and BTB domain-containing protein 26
RAB GTPase activating protein 1, transcript variant X1
RAB GTPase activating protein 1, transcript variant X2
rab GTPase-activating protein 1 isoform X1
rab GTPase-activating protein 1 isoform X2
RAB GTPase activating protein 1, transcript variant X3
rab GTPase-activating protein 1 isoform X3
uncharacterized LOC101942936, transcript variant X1
uncharacterized LOC101942936, transcript variant X7
uncharacterized LOC101942936, transcript variant X3
uncharacterized LOC101942936, transcript variant X6
uncharacterized LOC101942936, transcript variant X5
uncharacterized LOC101942936, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC101942936, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
spermatid perinuclear RNA binding protein, transcript variant X7
spermatid perinuclear RNA binding protein, transcript variant X8
spermatid perinuclear RNA binding protein, transcript variant X2
spermatid perinuclear RNA binding protein, transcript variant X6
spermatid perinuclear RNA binding protein, transcript variant X1
spermatid perinuclear RNA-binding protein isoform X8
spermatid perinuclear RNA-binding protein isoform X2
spermatid perinuclear RNA-binding protein isoform X6
spermatid perinuclear RNA-binding protein isoform X1
spermatid perinuclear RNA-binding protein isoform X7
spermatid perinuclear RNA binding protein, transcript variant X4
spermatid perinuclear RNA binding protein, transcript variant X3
spermatid perinuclear RNA-binding protein isoform X4
spermatid perinuclear RNA-binding protein isoform X3
spermatid perinuclear RNA binding protein, transcript variant X5
spermatid perinuclear RNA-binding protein isoform X5
crumbs cell polarity complex component 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
crumbs cell polarity complex component 2, transcript variant X3
crumbs cell polarity complex component 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
crumbs cell polarity complex component 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
crumbs cell polarity complex component 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
DENN domain containing 1A, transcript variant X4
DENN domain containing 1A, transcript variant X6
DENN domain containing 1A, transcript variant X3
DENN domain containing 1A, transcript variant X2
DENN domain containing 1A, transcript variant X5
DENN domain containing 1A, transcript variant X1
DENN domain containing 1A, transcript variant X7
DENN domain containing 1A, transcript variant X8
DENN domain containing 1A, transcript variant X9
DENN domain-containing protein 1A isoform X4
DENN domain-containing protein 1A isoform X6
DENN domain-containing protein 1A isoform X3
DENN domain-containing protein 1A isoform X2
DENN domain-containing protein 1A isoform X5
DENN domain-containing protein 1A isoform X1
DENN domain-containing protein 1A isoform X7
DENN domain containing 1A, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
DENN domain containing 1A, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
DENN domain-containing protein 1A isoform X9
DENN domain-containing protein 1A isoform X8
uncharacterized LOC101936478, transcript variant X3
uncharacterized LOC101936478, transcript variant X2
uncharacterized LOC101936478, transcript variant X1
NIMA related kinase 6, transcript variant X1
NIMA related kinase 6, transcript variant X2
serine/threonine-protein kinase Nek6 isoform X1
serine/threonine-protein kinase Nek6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
adhesion G protein-coupled receptor D2, transcript variant X2
adhesion G protein-coupled receptor D2, transcript variant X1
adhesion G protein-coupled receptor D2, transcript variant X3
adhesion G protein-coupled receptor D2, transcript variant X4
adhesion G-protein coupled receptor D2 isoform X3
adhesion G-protein coupled receptor D2 isoform X1
adhesion G-protein coupled receptor D2 isoform X2
nuclear receptor subfamily 5 group A member 1, transcript variant X2
nuclear receptor subfamily 5 group A member 1, transcript variant X3
nuclear receptor subfamily 5 group A member 1, transcript variant X1
nuclear receptor subfamily 6 group A member 1, transcript variant X2
nuclear receptor subfamily 6 group A member 1, transcript variant X1
nuclear receptor subfamily 6 group A member 1, transcript variant X4
nuclear receptor subfamily 6 group A member 1, transcript variant X3
nuclear receptor subfamily 6 group A member 1 isoform X2
nuclear receptor subfamily 6 group A member 1 isoform X1
nuclear receptor subfamily 6 group A member 1 isoform X4
nuclear receptor subfamily 6 group A member 1 isoform X3
suppressor of cancer cell invasion, transcript variant X1
suppressor of cancer cell invasion, transcript variant X2
suppressor of cancer cell invasion, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
suppressor of cancer cell invasion, transcript variant X8
suppressor of cancer cell invasion, transcript variant X4
suppressor of cancer cell invasion, transcript variant X3
suppressor of cancer cell invasion, transcript variant X5
suppressor of cancer cell invasion, transcript variant X6
actin related protein 2/3 complex subunit 5 like
actin-related protein 2/3 complex subunit 5-like protein
serine/threonine-protein phosphatase 6 catalytic subunit
Rab9 effector protein with kelch motifs, transcript variant X1
Rab9 effector protein with kelch motifs, transcript variant X3
Rab9 effector protein with kelch motifs, transcript variant X4
rab9 effector protein with kelch motifs isoform X1
rab9 effector protein with kelch motifs isoform X3
rab9 effector protein with kelch motifs isoform X4
Rab9 effector protein with kelch motifs, transcript variant X2
rab9 effector protein with kelch motifs isoform X2
heat shock protein family A (Hsp70) member 5, transcript variant X1
heat shock protein family A (Hsp70) member 5, transcript variant X2
heat shock protein family A (Hsp70) member 5, transcript variant X3
GTPase activating protein and VPS9 domains 1
GTPase-activating protein and VPS9 domain-containing protein 1
MAPK associated protein 1, transcript variant X2
MAPK associated protein 1, transcript variant X5
MAPK associated protein 1, transcript variant X3
MAPK associated protein 1, transcript variant X4
MAPK associated protein 1, transcript variant X1
target of rapamycin complex 2 subunit MAPKAP1 isoform X2
target of rapamycin complex 2 subunit MAPKAP1 isoform X5
target of rapamycin complex 2 subunit MAPKAP1 isoform X3
target of rapamycin complex 2 subunit MAPKAP1 isoform X4
target of rapamycin complex 2 subunit MAPKAP1 isoform X1
MAPK associated protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
MAPK associated protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
target of rapamycin complex 2 subunit MAPKAP1 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
pre-B-cell leukemia transcription factor 3 isoform X2
pre-B-cell leukemia transcription factor 3 isoform X4
pre-B-cell leukemia transcription factor 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
pre-B-cell leukemia transcription factor 3 isoform X1
pre-B-cell leukemia transcription factor 3 isoform X6
pre-B-cell leukemia transcription factor 3 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
pre-B-cell leukemia transcription factor 3 isoform X7
pre-B-cell leukemia transcription factor 3 isoform X8
multivesicular body subunit 12B, transcript variant X5
multivesicular body subunit 12B, transcript variant X6
multivesicular body subunit 12B, transcript variant X4
multivesicular body subunit 12B, transcript variant X1
multivesicular body subunit 12B, transcript variant X2
multivesicular body subunit 12B, transcript variant X8
multivesicular body subunit 12B, transcript variant X9
multivesicular body subunit 12B isoform X1
multivesicular body subunit 12B isoform X4
multivesicular body subunit 12B isoform X5
multivesicular body subunit 12B, transcript variant X3
multivesicular body subunit 12B isoform X2
multivesicular body subunit 12B, transcript variant X7
multivesicular body subunit 12B isoform X3
uncharacterized LOC112060150, transcript variant X1
uncharacterized LOC112060150, transcript variant X2
LIM homeobox transcription factor 1 beta
LIM homeobox transcription factor 1-beta
uncharacterized LOC101945588, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC101945588, transcript variant X1
uncharacterized LOC101945588, transcript variant X3
uncharacterized LOC101945588, transcript variant X2
zinc finger and BTB domain containing 43, transcript variant X1
zinc finger and BTB domain containing 43, transcript variant X2
zinc finger and BTB domain containing 34, transcript variant X3
zinc finger and BTB domain-containing protein 43
zinc finger and BTB domain containing 34, transcript variant X1
zinc finger and BTB domain-containing protein 34 isoform X1
zinc finger and BTB domain containing 34, transcript variant X2
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 34 isoform X2
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X5
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X8
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X13
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
Ral GEF with PH domain and SH3 binding motif 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ras-specific guanine nucleotide-releasing factor RalGPS1 isoform X1
ras-specific guanine nucleotide-releasing factor RalGPS1 isoform X2
ras-specific guanine nucleotide-releasing factor RalGPS1 isoform X3
solute carrier family 2 member 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
F-box and WD repeat domain containing 2, transcript variant X3
F-box and WD repeat domain containing 2, transcript variant X2
F-box and WD repeat domain containing 2, transcript variant X1
solute carrier family 2 member 8, transcript variant X3
solute carrier family 2 member 8, transcript variant X2
solute carrier family 2 member 8, transcript variant X1
solute carrier family 2 member 8, transcript variant X6
solute carrier family 2 member 8, transcript variant X5
solute carrier family 2, facilitated glucose transporter member 8 isoform X1
solute carrier family 2, facilitated glucose transporter member 8 isoform X3
solute carrier family 2, facilitated glucose transporter member 8 isoform X2
GTPase activating Rap/RanGAP domain like 3, transcript variant X11
GTPase activating Rap/RanGAP domain like 3, transcript variant X2
GTPase activating Rap/RanGAP domain like 3, transcript variant X1
GTPase activating Rap/RanGAP domain like 3, transcript variant X4
GTPase activating Rap/RanGAP domain like 3, transcript variant X8
GTPase activating Rap/RanGAP domain like 3, transcript variant X9
GTPase activating Rap/RanGAP domain like 3, transcript variant X5
GTPase activating Rap/RanGAP domain like 3, transcript variant X10
GTPase activating Rap/RanGAP domain like 3, transcript variant X6
GTPase activating Rap/RanGAP domain like 3, transcript variant X3
GTPase activating Rap/RanGAP domain like 3, transcript variant X7
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X8
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X1
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X5
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X3
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X7
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X2
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X4
GTPase-activating Rap/Ran-GAP domain-like protein 3 isoform X6